Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

Running, not enrolling · Phase 2 · Has a placebo group

Conditions studied: Atopic Dermatitis

In brief

The main purpose of this Ph2a study is to evaluate the preliminary efficacy, safety and tolerability of GIA632 when administered to adult participants with moderate to severe atopic dermatitis (AD).

Key facts

Study ID

NCT07220577

Run by

Novartis Pharmaceuticals

People needed

34

Starts

2025-11-10

Expected to finish

2027-09-06

Last updated by the study team

2026-05-14

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Ctr for Dermatology Clinical Res — Fremont, California, United States
• Aesthetics Skin Care Dermatologic Surgery — Rockville, Maryland, United States
• Care Access Hoboken — Hoboken, New Jersey, United States
• Novartis Investigative Site — Pleven, Bulgaria
• Novartis Investigative Site — Sofia, Bulgaria
• Novartis Investigative Site — Sofia, Bulgaria
• Novartis Investigative Site — Toronto, Ontario, Canada
• Novartis Investigative Site — Québec, Quebec, Canada
• Novartis Investigative Site — Ostrava, Poruba, Czechia
• Novartis Investigative Site — Brno, Czechia
• Novartis Investigative Site — Prague, Czechia
• Novartis Investigative Site — Antony, France
• Novartis Investigative Site — Dijon, France
• Novartis Investigative Site — Martigues, France
• Novartis Investigative Site — Nice, France
• Novartis Investigative Site — Berlin, Germany
• Novartis Investigative Site — Hamburg, Germany
• Novartis Investigative Site — Mainz, Germany
• Novartis Investigative Site — Ipoh, Perak, Malaysia
• Novartis Investigative Site — George Town, Pulau Pinang, Malaysia
• Novartis Investigative Site — Kota Kinabalu, Sabah, Malaysia
• Novartis Investigative Site — Kuala Lumpur, Malaysia
• Novartis Investigative Site — Gdansk, Poland
• Novartis Investigative Site — Torun, Poland
• Novartis Investigative Site — Warsaw, Poland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.